One study showed that in dextran sulfate sodium (DSS)-induced colitis, IFN-β offers protective benefits when induced via TLR9 and when administered in recombinant form during the course of colitis [31], although the effect on IL-17 expression was not reported. Here, IL17A is linked to colitis.